SAMHD1 and B-cell chronic lymphocytic leukemia: SAMHD1 mutations are found in 3%–5% of newly diagnosed CLL and expand in relapsed and refractory disease to a frequency of about 11% (Clifford et al., 2014, Landau et al., 2015).